# Advanced Drainage Systems, Inc.: financial statements, quarterly

WMS · NYSE · CIK 1604028 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/wms.md) · [Financials](/companies/wms/financials.md) · [Filings](/companies/wms/filings.md) · [Insiders](/companies/wms/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wms/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [780](/filings/0001604028-24-000044.md) | [662](/filings/0001604028-25-000005.md) | [654 d](/filings/0001604028-26-000019.md) | [815](/filings/0001604028-25-000030.md) | [783](/filings/0001604028-25-000043.md) | [691](/filings/0001604028-26-000007.md) | [616 d](/filings/0001604028-26-000019.md) | [830](/filings/0001604028-26-000037.md) | [850](/filings/0001604028-25-000043.md) | [693](/filings/0001604028-26-000007.md) | [677 d](/filings/0001604028-26-000019.md) | [1,001](/filings/0001604028-26-000037.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [303](/filings/0001604028-24-000044.md) | [260](/filings/0001604028-25-000005.md) | [252 d](/filings/0001604028-26-000019.md) | [332](/filings/0001604028-25-000030.md) | [294](/filings/0001604028-25-000043.md) | [242](/filings/0001604028-26-000007.md) | [226 d](/filings/0001604028-26-000019.md) | [330](/filings/0001604028-26-000037.md) | [340](/filings/0001604028-25-000043.md) | [259](/filings/0001604028-26-000007.md) | [238 d](/filings/0001604028-26-000019.md) | [408](/filings/0001604028-26-000037.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [198](/filings/0001604028-24-000044.md) | [153](/filings/0001604028-25-000005.md) | [135 d](/filings/0001604028-26-000019.md) | [226](/filings/0001604028-25-000030.md) | [187](/filings/0001604028-25-000043.md) | [127](/filings/0001604028-26-000007.md) | [117 d](/filings/0001604028-26-000019.md) | [206](/filings/0001604028-26-000037.md) | [223](/filings/0001604028-25-000043.md) | [137](/filings/0001604028-26-000007.md) | [53.3 d](/filings/0001604028-26-000019.md) | [255](/filings/0001604028-26-000037.md) |
| Income tax | $m | [47.5](/filings/0001604028-24-000044.md) | [30.1](/filings/0001604028-25-000005.md) | [26.3 d](/filings/0001604028-26-000019.md) | [49.9](/filings/0001604028-25-000030.md) | [40.9](/filings/0001604028-25-000043.md) | [27.1](/filings/0001604028-26-000007.md) | [23.2 d](/filings/0001604028-26-000019.md) | [46.7](/filings/0001604028-26-000037.md) | [52.4](/filings/0001604028-25-000043.md) | [30.6](/filings/0001604028-26-000007.md) | [5.4 d](/filings/0001604028-26-000019.md) | [53.7](/filings/0001604028-26-000037.md) |
| Net income | $m | [136](/filings/0001604028-24-000044.md) | [106](/filings/0001604028-25-000005.md) | [94.8 d](/filings/0001604028-26-000019.md) | [161](/filings/0001604028-25-000030.md) | [130](/filings/0001604028-25-000043.md) | [81.2](/filings/0001604028-26-000007.md) | [77.2 d](/filings/0001604028-26-000019.md) | [144](/filings/0001604028-26-000037.md) | [156](/filings/0001604028-25-000043.md) | [93.6](/filings/0001604028-26-000007.md) | [32.9 d](/filings/0001604028-26-000019.md) | [169](/filings/0001604028-26-000037.md) |
| Diluted EPS | $ per share | [1.71](/filings/0001604028-24-000044.md) | [1.34](/filings/0001604028-25-000005.md) | not reported | [2.06](/filings/0001604028-25-000030.md) | [1.67](/filings/0001604028-25-000043.md) | [1.04](/filings/0001604028-26-000007.md) | not reported | [1.84](/filings/0001604028-26-000037.md) | [1.99](/filings/0001604028-25-000043.md) | [1.19](/filings/0001604028-26-000007.md) | not reported | [2.19](/filings/0001604028-26-000037.md) |
| Basic EPS | $ per share | [1.73](/filings/0001604028-24-000044.md) | [1.36](/filings/0001604028-25-000005.md) | not reported | [2.08](/filings/0001604028-25-000030.md) | [1.68](/filings/0001604028-25-000043.md) | [1.05](/filings/0001604028-26-000007.md) | not reported | [1.85](/filings/0001604028-26-000037.md) | [2.01](/filings/0001604028-25-000043.md) | [1.20](/filings/0001604028-26-000007.md) | not reported | [2.20](/filings/0001604028-26-000037.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [470](/filings/0001604028-23-000050.md) | [561](/filings/0001604028-24-000005.md) | [490](/filings/0001604028-26-000019.md) | [542](/filings/0001604028-25-000030.md) | [613](/filings/0001604028-25-000043.md) | [489](/filings/0001604028-26-000007.md) | [463](/filings/0001604028-26-000019.md) | [638](/filings/0001604028-26-000037.md) | [813](/filings/0001604028-25-000043.md) | [1,008](/filings/0001604028-26-000007.md) | [223](/filings/0001604028-26-000037.md) | [162](/filings/0001604028-26-000037.md) |
| Current assets | $m | [1,232](/filings/0001604028-23-000050.md) | [1,238](/filings/0001604028-24-000005.md) | [1,300](/filings/0001604028-25-000012.md) | [1,424](/filings/0001604028-24-000032.md) | [1,492](/filings/0001604028-24-000044.md) | [1,245](/filings/0001604028-25-000005.md) | [1,325](/filings/0001604028-26-000019.md) | [1,517](/filings/0001604028-25-000030.md) | [1,673](/filings/0001604028-25-000043.md) | [1,705](/filings/0001604028-26-000007.md) | [1,231](/filings/0001604028-26-000037.md) | [1,241](/filings/0001604028-26-000037.md) |
| Total assets | $m | [3,138](/filings/0001604028-23-000050.md) | [3,162](/filings/0001604028-24-000005.md) | [3,269](/filings/0001604028-25-000012.md) | [3,448](/filings/0001604028-24-000032.md) | [3,536](/filings/0001604028-24-000044.md) | [3,602](/filings/0001604028-25-000005.md) | [3,690](/filings/0001604028-26-000019.md) | [3,910](/filings/0001604028-25-000030.md) | [4,079](/filings/0001604028-25-000043.md) | [4,144](/filings/0001604028-26-000007.md) | [4,506](/filings/0001604028-26-000037.md) | [4,510](/filings/0001604028-26-000037.md) |
| Current liabilities | $m | [428](/filings/0001604028-23-000050.md) | [409](/filings/0001604028-24-000005.md) | [440](/filings/0001604028-25-000012.md) | [493](/filings/0001604028-24-000032.md) | [467](/filings/0001604028-24-000044.md) | [388](/filings/0001604028-25-000005.md) | [398](/filings/0001604028-26-000019.md) | [472](/filings/0001604028-25-000030.md) | [481](/filings/0001604028-25-000043.md) | [413](/filings/0001604028-26-000007.md) | [509](/filings/0001604028-26-000037.md) | [586](/filings/0001604028-26-000037.md) |
| Total liabilities | $m | [1,956](/filings/0001604028-23-000050.md) | [1,940](/filings/0001604028-24-000005.md) | [1,988](/filings/0001604028-25-000012.md) | [2,063](/filings/0001604028-24-000032.md) | [2,043](/filings/0001604028-24-000044.md) | [2,038](/filings/0001604028-25-000005.md) | [2,055](/filings/0001604028-26-000019.md) | [2,132](/filings/0001604028-25-000030.md) | [2,150](/filings/0001604028-25-000043.md) | [2,115](/filings/0001604028-26-000007.md) | [2,550](/filings/0001604028-26-000037.md) | [2,620](/filings/0001604028-26-000037.md) |
| Long-term debt | $m | [1,264](/filings/0001604028-23-000050.md) | [1,262](/filings/0001604028-24-000005.md) | [1,260](/filings/0001604028-25-000012.md) | [1,257](/filings/0001604028-24-000032.md) | [1,255](/filings/0001604028-24-000044.md) | [1,253](/filings/0001604028-25-000005.md) | [1,252](/filings/0001604028-26-000019.md) | [1,250](/filings/0001604028-25-000030.md) | [1,249](/filings/0001604028-25-000043.md) | [1,276](/filings/0001604028-26-000007.md) | [1,606](/filings/0001604028-26-000037.md) | [1,605](/filings/0001604028-26-000037.md) |
| Current portion of debt | $m | [13.0](/filings/0001604028-23-000050.md) | [12.3](/filings/0001604028-24-000005.md) | [11.9](/filings/0001604028-25-000012.md) | [11.5](/filings/0001604028-24-000032.md) | [11.1](/filings/0001604028-24-000044.md) | [10.6](/filings/0001604028-25-000005.md) | [9.9](/filings/0001604028-26-000019.md) | [9.3](/filings/0001604028-25-000030.md) | [8.7](/filings/0001604028-25-000043.md) | [6.5](/filings/0001604028-26-000007.md) | [5.9](/filings/0001604028-26-000037.md) | [7.7](/filings/0001604028-26-000037.md) |
| Shareholders' equity | $m | [1,029](/filings/0001604028-23-000050.md) | [1,079](/filings/0001604028-24-000005.md) | [1,153](/filings/0001604028-25-000012.md) | [1,263](/filings/0001604028-24-000032.md) | [1,376](/filings/0001604028-24-000044.md) | [1,451](/filings/0001604028-25-000005.md) | [1,525](/filings/0001604028-26-000019.md) | [1,671](/filings/0001604028-25-000030.md) | [1,826](/filings/0001604028-25-000043.md) | [1,928](/filings/0001604028-26-000007.md) | [1,859](/filings/0001604028-26-000037.md) | [1,792](/filings/0001604028-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [215 d](/filings/0001604028-24-000044.md) | [241 d](/filings/0001604028-25-000005.md) | [17.7 d](/filings/0001604028-26-000019.md) | [183](/filings/0001604028-25-000030.md) | [167 d](/filings/0001604028-25-000043.md) | [190 d](/filings/0001604028-26-000007.md) | [41.2 d](/filings/0001604028-26-000019.md) | [275](/filings/0001604028-26-000037.md) | [235 d](/filings/0001604028-25-000043.md) | [269 d](/filings/0001604028-26-000007.md) | [39.9 d](/filings/0001604028-26-000019.md) | [260](/filings/0001604028-26-000037.md) |
| Capital expenditure | $m | [40.5](/filings/0001604028-23-000050.md) | [53.8 d](/filings/0001604028-25-000005.md) | [47.4 d](/filings/0001604028-26-000019.md) | [57.7](/filings/0001604028-25-000030.md) | [54.5 d](/filings/0001604028-25-000043.md) | [54.2 d](/filings/0001604028-26-000007.md) | [46.5 d](/filings/0001604028-26-000019.md) | [52.6](/filings/0001604028-26-000037.md) | [58.4 d](/filings/0001604028-25-000043.md) | [85.7 d](/filings/0001604028-26-000007.md) | [53.0 d](/filings/0001604028-26-000019.md) | [57.2](/filings/0001604028-26-000037.md) |
| Dividends paid | $m | [11.1 d](/filings/0001604028-24-000044.md) | [10.9 d](/filings/0001604028-25-000005.md) | [10.9 d](/filings/0001604028-26-000019.md) | [12.4](/filings/0001604028-25-000030.md) | [12.5 d](/filings/0001604028-25-000043.md) | [12.4 d](/filings/0001604028-26-000007.md) | [12.4 d](/filings/0001604028-26-000019.md) | [14.0](/filings/0001604028-26-000037.md) | [14.1 d](/filings/0001604028-25-000043.md) | [14.0 d](/filings/0001604028-26-000007.md) | [14.0 d](/filings/0001604028-26-000019.md) | [15.3](/filings/0001604028-26-000037.md) |
| Share repurchases | $m | [53.8 d](/filings/0001604028-24-000044.md) | [76.6 d](/filings/0001604028-25-000005.md) | [29.1 d](/filings/0001604028-26-000019.md) | [49.2](/filings/0001604028-25-000030.md) | [20.7 d](/filings/0001604028-25-000043.md) | [0.0 d](/filings/0001604028-26-000007.md) | [0.0 d](/filings/0001604028-26-000019.md) | [0.0](/filings/0001604028-26-000037.md) | [0.0 d](/filings/0001604028-25-000043.md) | [0.0 d](/filings/0001604028-26-000007.md) | [92.0 d](/filings/0001604028-26-000019.md) | [233](/filings/0001604028-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q3 FY2024 (2023-06-30) | Q3 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [84.5](/filings/0001604028-23-000050.md) | [83.0](/filings/0001604028-24-000005.md) | [79.6](/filings/0001604028-24-000032.md) | [79.3](/filings/0001604028-24-000044.md) | [78.6](/filings/0001604028-25-000005.md) | [78.3](/filings/0001604028-25-000030.md) | [78.1](/filings/0001604028-25-000043.md) | [78.1](/filings/0001604028-26-000007.md) | [78.1](/filings/0001604028-26-000037.md) | [78.3](/filings/0001604028-25-000043.md) | [78.4](/filings/0001604028-26-000007.md) | [77.0](/filings/0001604028-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 75,405,342 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001604028-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.